• Skip to main content
  • Skip to footer

PeDRA

Pediatric Dermatology Research Alliance

  • DONATE
  • Pay 2023 Membership Dues
  • Join PeDRA
  • Login
MENUMENU
  • Contact Us
  • For Patients & Families
        • Patient Support
        • Patient Education
        • Community Spotlight
        • Play Eczema Counts Now!
        • Patient Advisory Committee
        • Find a Pediatric Dermatologist (from SPD)
        • Parents, advocates, and patients over the age of 18 with a direct connection or significant interest in childhood skin disease or pediatric dermatology research are encouraged to join the PeDRA network for free as Community Members.

          Apply Now!

  • Education and Events
        • Virtual Education
        • SPD/PeDRA Journal Club
        • PeDRA Podcasts
        • Points of Discussion Podcast
        • Mentorship Program
        • 2023 Annual Conference
        • Dash for Discovery Fun Run/Walk
        • Early Investigator Support
        • Play Eczema Counts Now!
        • Events Calendar
        • Save the Date! The 2023 PeDRA Annual Conference will be held November 9-11, 2023 at the Westin Buckhead Atlanta in Atlanta, GA.

           

           

          Explore our new educational catalog!

  • Research
        • Grants and Fellowships
        • Resources for Researchers
        • Survey Application
        • Study Application
        • Research Areas
        • Publications
        • Now accepting applications for the Emerging Investigator Research Grants Program.

  • About
        • Mission & Vision
        • Leadership & Staff
        • Annual Reports & Financials
        • News Archive
        • Our Supporters
        • Our Membership
        • Our Committees
        • Getting to Know You
        • 2022 marked PeDRA’s 10th year of pursuing the vision of changing lives and healing children with skin disease through collaboration and discovery. Visit our 10th Anniversary Page to learn more about the origin of PeDRA and the many accomplishments during the first ten years!

  • Member Login

Hypopigmented mycosis fungoides True lymphoma or T-cell dyscrasia: A Retrospective and prospective cohort study

June 6, 2022 By Katherine Devenport

Fellow

Yaron Noam Zafrir
SickKids Hospital – Toronto, Canada

Mentor

Elena Pope, MD
SickKids Hospital – Toronto, Canada

Overview

The most common CTCL in children is hypopigmented mycosis fungoides (HMF). Since its first description a large number of HMF cases were reported to have unusual clinical and pathological findings, questioning the true nature of HMF as CTCL. It has been suggested to separate HMF from MF and to define those cases as cutaneous T cell lymphoid dyscrasias (CTLD), with dyscrasia representing an abnormal or unbalanced state rather than true cancer. Our hypothesis is that a subset of patients with MF, particularly those with a HMF, could be reclassified as hypopigmented T-cell dyscrasia. We propose to conduct a retrospective and prospective cohort study to determine whether childhood HMF is a CTCL or CTLD.
Expanding our understanding regarding presentation, pathological patterns, clinical course, management and follow ups will enable physicians to label these patients correctly and alleviate a lot of the anxiety associated with a cancer diagnosis.

Status

This project was funded through a 2022 PeDRA Research Fellowship Grant.

Filed Under: Skin Tumors and Reactions to Cancer Therapies

Footer

  • Our Membership
  • For Patients
  • For Researchers
  • Governance Policies
  • Financial Conflict of Interest Policy
  • Jobs at PeDRA
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube
Sign up to receive emails from PeDRA
Join PeDRA
Donate

Copyright © 2023 · Pediatric Dermatology Research Alliance (PeDRA) · All Rights Reserved. · Privacy Policy